Human apurinic/apyrimidinic endonuclease 1 translocalizes to mitochondria after photodynamic therapy and protects cells from apoptosis

Cancer Science

Volumn 103, Issue 5, 2012, Pages 882-888

  Li, Meng Xia ^a   Shan, Jin Lu ^a   Wang, Dong ^a   He, Yong ^a   Zhou, Qian ^a   Xia, Lei ^a   Zeng, Lin Li ^a   Li, Zeng Peng ^b   Wang, Ge ^a   Yang, Zhen Zhou ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APURINIC APYRIMIDINIC ENDONUCLEASE 1; ENDONUCLEASE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY;

EID: 84860230332     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02239.x     Document Type: Article

References (26)

1. Simeonov A, Kulkarni A, Dorjsuren D et al. Identification and characterization of inhibitors of human apurinic/apyrimidinic endonuclease APE1. PLoS ONE 2009; 4: e5740.
2. Buytaert E, Dewaele M, Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 2007; 1776: 86-107.
3. Kessel D, Sun HH. Enhanced responsiveness to photodynamic therapy-induced apoptosis after mitochondrial DNA depletion. Photochem Photobiol 1999; 70: 937-40.
4. Moor AC. Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol, B 2000; 57: 1-13.
5. Srivastava DK, Berg BJ, Prasad R et al.Mammalian abasic site base excision repair. Identification of the reaction sequence and rate-determining steps. J Biol Chem 1998; 273: 21203-9.
6. Tomkinson AE, Bonk RT, Linn S. Mitochondrial endonuclease activities specific for apurinic/apyrimidinic sites in DNA from mouse cells. J Biol Chem 1988; 263: 12532-7.
7. Tell G, Damante G, Caldwell D, Kelley MR. The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal 2005; 7: 367-84.
8. Frossi B, Tell G, Spessotto P, Colombatti A, Vitale G, Pucillo C. H(2)O(2) induces translocation of APE/Ref-1 to mitochondria in the Raji B-cell line. J Cell Physiol 2002; 193: 180-6.
9. Li MX, Wang D, Zhong ZY et al. Targeting truncated APE1 in mitochondria enhances cell survival after oxidative stress. Free Radic Biol Med 2008; 45: 592-601.
10. Evans AR, Limp-Foster M, Kelley MR. Going APE over ref-1. Mutat Res 2000; 461: 83-108.
11. Tell G, Fantini D, Quadrifoglio F. Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment. Cell Mol Life Sci 2010; 67: 3589-608.
12. Aditi Bapat MF, Kelley MR. Going ape as an approach to cancer therapeutics. Antioxid Redox Signal 2009; 11: 651-67.
13. Yang ZZ, Li MX, Zhang YS et al. Knock down of the dual functional protein apurinic/apyrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model. Cancer Sci 2010; 101: 180-7.
14. Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 2004; 3: 679-86.
15. Li M, Zhong Z, Zhu J et al. Identification and characterization of mitochondrial targeting sequence of human apurinic/apyrimidinic endonuclease 1. J Biol Chem 2010; 285: 14871-81.
16. Perkins CL, Fang G, Kim CN, Bhalla KN. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res 2000; 60: 1645-53.
17. Waterhouse NJ, Goldstein JC, von Ahsen O, Schuler M, Newmeyer DD, Green DR. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 2001; 153: 319-28.
18. Vascotto C, Bisetto E, Li M et al. Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function. Mol Biol Cell 2011; 22: 3887-901.
19. Vascotto C, Cesaratto L, Zeef LA et al. Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 2009; 9: 1058-74.
20. Ishii N. Role of oxidative stress from mitochondria on aging and cancer. Cornea 2007; 26: S3-9.
21. Vascotto C, Fantini D, Romanello M et al. APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process. Mol Cell Biol 2009; 29: 1834-54.
22. Kang D, Kim SH, Hamasaki N. Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion 2007; 7: 39-44.
23. Canugovi C, Maynard S, Bayne AC et al. The mitochondrial transcription factor A functions in mitochondrial base excision repair. DNA Repair (Amst) 2010; 9: 1080-9.
24. Georgiadis MM, Luo M, Gaur RK, Delaplane S, Li X, Kelley MR. Evolution of the redox function in mammalian apurinic/apyrimidinic endonuclease. Mutat Res 2008; 643: 54-63.
25. Maher RL, Bloom LB. Pre-steady-state kinetic characterization of the AP endonuclease activity of human AP endonuclease 1. J Biol Chem 2007; 282: 30577-85.
26. Chattopadhyay R, Wiederhold L, Szczesny B et al. Identification and characterization of mitochondrial abasic (AP)-endonuclease in mammalian cells. Nucleic Acids Res 2006; 34: 2067-76.